Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | RXRA | P19793 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 2/20 | 0.32 |
| ▸ | F7 | P08709 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | F3 | P13726 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28134376 | 0.81 | ALDH1A1 (0.35) | ALDH1A1CYP19A1RXRAPPARGOXER1 | |
| SCHEMBL8989609 | 0.75 | ALDH1A1 (0.38) | ALDH1A1CYP19A1RXRAPPARGOXER1 | |
| SCHEMBL11301760 | 0.75 | ALDH1A1 (0.38) | ALDH1A1CYP19A1RXRAPPARGOXER1 | |
| SCHEMBL10978361 | 0.71 | EPHX2 (0.41) | ALDH1A1CYP19A1RXRAPPARGOXER1 | |
| SCHEMBL19526875 | 0.69 | — | — | |
| SCHEMBL20376216 | 0.68 | ALDH1A1 (0.33) | ALDH1A1CYP19A1RXRAPPARGOXER1 | |
| SCHEMBL14617949 | 0.65 | ALDH1A1 (0.41) | ALDH1A1CYP19A1RXRAPPARGOXER1 | |
| SCHEMBL2363271 | 0.64 | ALDH1A1 (0.43) | ALDH1A1CYP19A1RXRAPPARGOXER1 | |
| SCHEMBL19751288 | 0.64 | ALDH1A1 (0.43) | ALDH1A1CYP19A1RXRAPPARGOXER1 | |
| SCHEMBL2363268 | 0.64 | ALDH1A1 (0.43) | ALDH1A1CYP19A1RXRAPPARGOXER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020102100-A9 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS AG (CH) | 2022-01-06 | — | — | WO | disclosed |
| WO-2020102100-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS INFLAMMASOME RESEARCH, INC. (US) | 2020-05-22 | — | — | WO | disclosed |